Class information for:
Level 1: NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG//IMMUNIZATION FINANCING//PROVAC INITIAT

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19570 435 25.8 43%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1009 9870 PERTUSSIS//BORDETELLA PERTUSSIS//WHOOPING COUGH

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG Author keyword 6 80% 1% 4
2 IMMUNIZATION FINANCING Author keyword 6 71% 1% 5
3 PROVAC INITIAT Address 6 100% 1% 4
4 NEW VACCINES Author keyword 4 36% 2% 10
5 VACCINE SUPPLY CHAIN Author keyword 4 67% 1% 4
6 VACCINE WASTAGE Author keyword 4 67% 1% 4
7 ADVISORY GROUP Author keyword 4 75% 1% 3
8 GAVI ALLIANCE Author keyword 4 56% 1% 5
9 ADVISORY COMMITTEE Author keyword 4 30% 3% 11
10 NEW VACCINE INTRODUCTION Author keyword 3 100% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUP NITAG 6 80% 1% 4 Search NATIONAL+IMMUNIZATION+TECHNICAL+ADVISORY+GROUP+NITAG Search NATIONAL+IMMUNIZATION+TECHNICAL+ADVISORY+GROUP+NITAG
2 IMMUNIZATION FINANCING 6 71% 1% 5 Search IMMUNIZATION+FINANCING Search IMMUNIZATION+FINANCING
3 NEW VACCINES 4 36% 2% 10 Search NEW+VACCINES Search NEW+VACCINES
4 VACCINE SUPPLY CHAIN 4 67% 1% 4 Search VACCINE+SUPPLY+CHAIN Search VACCINE+SUPPLY+CHAIN
5 VACCINE WASTAGE 4 67% 1% 4 Search VACCINE+WASTAGE Search VACCINE+WASTAGE
6 ADVISORY GROUP 4 75% 1% 3 Search ADVISORY+GROUP Search ADVISORY+GROUP
7 GAVI ALLIANCE 4 56% 1% 5 Search GAVI+ALLIANCE Search GAVI+ALLIANCE
8 ADVISORY COMMITTEE 4 30% 3% 11 Search ADVISORY+COMMITTEE Search ADVISORY+COMMITTEE
9 NEW VACCINE INTRODUCTION 3 100% 1% 3 Search NEW+VACCINE+INTRODUCTION Search NEW+VACCINE+INTRODUCTION
10 VIAL SIZE 3 100% 1% 3 Search VIAL+SIZE Search VIAL+SIZE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TECHNICAL ADVISORY GROUPS 3 50% 1% 5
2 HYPOTHETICAL MALARIA VACCINES 3 100% 1% 3
3 PAPILLOMAVIRUS VACCINE 2 67% 0% 2
4 PNEUMOCOCCAL CONJUGATE VACCINATION 2 26% 1% 5
5 GROUPS NITAGS 1 100% 0% 2
6 POOREST COUNTRIES 1 100% 0% 2
7 IMMUNIZATION PROGRAMS 1 10% 2% 10
8 REVOLVING FUND 1 40% 0% 2
9 SABIN IPV 1 40% 0% 2
10 GAVI 1 27% 1% 3

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience 2013 7 3 100%
Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020 2013 6 4 100%
National decision-making on adopting new vaccines: a systematic review 2012 10 17 59%
Public vaccine manufacturing capacity in the Latin American and Caribbean region: Current status and perspectives 2012 4 6 100%
Delivering the promise of the Decade of Vaccines: Opportunities and challenges in the development of high quality new vaccines 2013 5 6 67%
Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) 2011 28 17 41%
Twenty-five years of the WHO vaccines prequalification programme (1987-2012): Lessons learned and future perspectives 2015 1 3 67%
Decision support in vaccination policies 2009 14 3 67%
The imperative for stronger vaccine supply and logistics systems 2013 8 12 42%
Global support for new vaccine implementation in middle-income countries 2013 6 2 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROVAC INITIAT 6 100% 0.9% 4
2 IMMUNIZAT VACCINES BIOL 3 13% 5.3% 23
3 ADVISORY COMM IMMUNIZAT PRACTICES 3 60% 0.7% 3
4 COMPREHENS FAMILY IMMUNIZAT PROJECT 3 32% 1.6% 7
5 IVAC 2 43% 0.7% 3
6 HDNHE 1 50% 0.5% 2
7 COMPREHENS FAMILY IMMUNIZAT 1 30% 0.7% 3
8 VACCINE PREVENTABLE DIS IMMUNIZAT PROGRAMME 1 40% 0.5% 2
9 IMMUNIZAT UNIT 1 11% 1.6% 7
10 CHILDRENS VACCINE PROGRAM 1 33% 0.5% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000123311 IMMUNIZAT PROGRAM//IMMUNIZATION//VACCINE HESITANCY
2 0.0000104863 HAEMOPHILUS INFLUENZAE TYPE B//HIB//HAEMOPHILUS INFLUENZAE TYPE B VACCINE
3 0.0000094288 ALUMINUM HYDROXIDE ADJUVANT//ANTIGEN ADSORPTION//MACROPHAGIC MYOFASCIITIS
4 0.0000087412 GLOBAL HEALTH INITIATIVES//GLOBAL FUND//GLOBAL HEALTH GOVERNANCE
5 0.0000074856 DRUG SHORTAGES//VACCINE STOCKPILES//VACCINE SHORTAGE
6 0.0000073766 DEVELOPMENT OF SOCIETIES//INDIGENOUS ACCREDITATION//MT ROMANCE
7 0.0000072243 ROTAVIRUS//ROTAVIRUS VACCINE//ROTAVIRUS VACCINES
8 0.0000071770 HLTH STUDIES AREA//PAYSON INT DEV TECHNOL TRANSFER//BIOTECHNOL FDN
9 0.0000067963 ORPHAN DRUGS//RARE DISEASES//OFF ORPHAN PROD DEV
10 0.0000064898 PROGRAM LIFE SCI ETH POLICY//MCLAUGHLIN ROTMAN GLOBAL HLTH//ESRC INNOGEN